Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Investment Chat Board Lawsuits -- Ignore unavailable to you. Want to Upgrade?

To: StockDung who wrote (5513)	1/7/2004 8:09:35 AM
From: scion	Read Replies (1) \| Respond to of 12465

Biomoda Inc 8301 Washington NE, Suite 5 Albuquerque NM 87113 USA Phone: 505-821-0875 -------------------------------------------------------------------------------- Add to Alert-My-IPO! Engaged in the business of developing biopharmaceutical technology to diagnose and treat human diseases. CEO: John J Cousins CFO: John J Cousins Filed on: 00/00/00 Ticker: -TBA- Exchange: OTCBB Price: $3 -------------------------------------------------------------------------------- Status -TBA- Revenue $ Net Income $ Lead Underwriter Self-Underwritten Est. Offering Amount $15M Shares 5,000,000 Shares Offered by Company ALL Est. Offering Expenses $ Post-Offering Shares 10,765,282 SIC State of Incorporation NM Employees, Full-time\|Part-time 3 Fiscal Year-End 12/31 Lockup Period 0 alert-ipo.com

To: StockDung who wrote (5513)	1/7/2004 9:35:53 AM
From: scion	Respond to of 12465

Advisory Staff & Management -------------------------------------------------------------------------------- Robert L. Youngblood, M.D.: President click here Ari Ma'ayan: Corporate Structuring & Technology Development Advisory Consultant. click here Jeffrey L. Garwin, M.D., Ph.D.: Scientific Advisory Consultant. click here Terry Michael DeRouin: Scientific Advisory Consultant. click here Craig W. Morrison, M.D.: Scientific Advisory Consultant. click here Shohreh Iravani, M.D.: Scientific Advisory Consultant. click here Investor Relations -------------------------------------------------------------------------------- National Financial Communications click here Investor Relations Specialist: Clint Marchant @ (801) 631-9681 or via e-mail at clint_marchant@NationalFC.com